FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to intravaginal drug delivery system the above system (5) comprises at least one portion (1a and 1b), comprising an inner portion (2) with a cross-section diameter d2 equal to 2-10 mm, and a membrane (3) covering the inner portion, wherein the inner portion and the membrane substantially consist of the same polymer structure or various polymer structures. Besides, the intravaginal drug delivery system comprises a connector (6) permeable for a therapeutically active substances with the cross-section diameter d6 equal to 0.5-4.0mm for forming the continuous working drug delivery system. The present invention also refers to a method for making the above intravaginal drug delivery system.
EFFECT: invention provides the controlled release rate of the therapeutically active substances.
12 cl, 4 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DELIVERY SYSTEM | 2005 |
|
RU2412693C2 |
| METHOD FOR PREPARING A DRUG DELIVERY DEVICE AND A DRUG DELIVERY DEVICE MADE BY SAID METHOD | 2016 |
|
RU2732822C2 |
| INTRAUTERINE DELIVERY SYSTEM | 1994 |
|
RU2121824C1 |
| INTRAVAGINAL DEVICE FOR DRUG DELIVERY | 2012 |
|
RU2607179C2 |
| DEVICE FOR DELIVERING MEDICINAL AGENTS OF ANTI-PROGESTINE ACTIVITY | 2000 |
|
RU2228170C2 |
| INTRAUTERINE SYSTEM FOR THERAPEUTIC APPLICATION | 2010 |
|
RU2529477C2 |
| METHOD FOR MODIFIED RELEASE OF THERAPEUTICALLY ACTIVE AGENT FROM ELASTOMERIC MATRIX | 2018 |
|
RU2780242C2 |
| INTRAUTERINE CARRIER | 2008 |
|
RU2503431C2 |
| IMPLANTABLE DEVICE AND METHOD OF FLUID DRUG DELIVERY TO TISSUE | 2007 |
|
RU2423154C2 |
| INTRAVAGINAL DEVICE FOR CONTROLLED DELIVERY OF LUBRICANTS | 2011 |
|
RU2591786C2 |
